Review of Heart-Lung Transplantation at Stanford

Tobias Deuse; Ramachandra Sista; David Weill; Dolly Tyan; Francois Haddad; Gundeep Dhillon; Robert C. Robbins; Bruce A. Reitz

doi:10.1016/j.athoracsur.2010.01.023

Review of Heart-Lung Transplantation at Stanford

Tobias Deuse, Ramachandra Sista, David Weill, Dolly Tyan, Francois Haddad, Gundeep Dhillon, Robert C. Robbins, Bruce A. Reitz

Pulmonary Medicine

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.

Original language	English (US)
Pages (from-to)	329-337
Number of pages	9
Journal	Annals of Thoracic Surgery
Volume	90
Issue number	1
DOIs	https://doi.org/10.1016/j.athoracsur.2010.01.023
State	Published - Jul 2010

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2010.01.023

Cite this

@article{b3a8d36dcae545818212a300ee3c5922,

title = "Review of Heart-Lung Transplantation at Stanford",

abstract = "Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.",

author = "Tobias Deuse and Ramachandra Sista and David Weill and Dolly Tyan and Francois Haddad and Gundeep Dhillon and Robbins, {Robert C.} and Reitz, {Bruce A.}",

year = "2010",

month = jul,

doi = "10.1016/j.athoracsur.2010.01.023",

language = "English (US)",

volume = "90",

pages = "329--337",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "1",

}

TY - JOUR

T1 - Review of Heart-Lung Transplantation at Stanford

AU - Deuse, Tobias

AU - Sista, Ramachandra

AU - Weill, David

AU - Tyan, Dolly

AU - Haddad, Francois

AU - Dhillon, Gundeep

AU - Robbins, Robert C.

AU - Reitz, Bruce A.

PY - 2010/7

Y1 - 2010/7

N2 - Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.

AB - Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.

UR - http://www.scopus.com/inward/record.url?scp=77953599249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953599249&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2010.01.023

DO - 10.1016/j.athoracsur.2010.01.023

M3 - Review article

C2 - 20609821

AN - SCOPUS:77953599249

SN - 0003-4975

VL - 90

SP - 329

EP - 337

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 1

ER -

Review of Heart-Lung Transplantation at Stanford

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this